For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
Jump to a slide with the slide dots.
Richard Lawrence
The pharmaceutical industry is increasingly globalized, with companies operating in multiple countries and serving multifaceted patient populations. T
Read moreInizio experts share insights ahead of ASH® 2025, helping pharma turn hematology’s complexity into strategic clarity and measurable impact.
Read moreLet’s get one thing clear: AI is not here to replace Medical Affairs professionals.
Read more